患有妊娠前的母亲出生的新生儿的尿路生物标志物:一个病例控制研究
Praveen Kumar1, Vimal Master Sankar Raj1, Diana Warnecke1
1Department of Pediatrics, University of Illinois College of Medicine, Peoria, United States of America.
Early human development
|December 4, 2024
概括
出生于孕前 (PE) 的母亲的婴儿表现出更高的尿蛋白和肌素,表明潜在的不成熟. 这些发现凸显了母体PE对胎儿脏发育的影响.
科学领域:
- 新生儿研究新生儿研究
- 脏生理学 脏生理学
- 孕产妇和胎儿的医学
背景情况:
- 孕前 (PE) 对胎儿脏发育的影响在很大程度上是未知的.
- 母亲PE可能会对胎儿脏发育产生不利影响,原因是循环因素导致内皮功能障碍.
研究的目的:
- 为了比较患有孕前症 (PE) 和没有孕前症 (PE) 的母亲生下的婴儿的尿路生物标志物.
主要方法:
- 从68对母婴新生儿 (妊娠年龄≥32周) 中,在出生后48小时内收集婴儿尿液样本.
- 测量了尿路生物标志物,包括肌素,蛋白质,囊素C,尼夫林,损伤分子-1和klotho.
- 分析了患有PE和没有PE的母亲生下的婴儿的样本.
主要成果:
- 与对照组相比,PE组的婴儿的身体长度较小.
- 在患有PE的母亲的婴儿中观察到明显更高的尿蛋白和肌素水平.
- 尿中的蛋白质,肌素和氨酸度与妊娠年龄有负相关性.
结论:
- 尿中蛋白质升高和尿中尼弗林和克洛托的趋势表明,在暴露于母体PE的婴儿中,淋巴细胞不成熟或功能受损.
- 研究结果表明,对于患有PE暴露的婴儿,可能会产生长期的影响.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
57
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
57
01:33Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K
01:07Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K